Tower Research Capital LLC (TRC) - FIBROGEN INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$10,402
-79.8%
12,053
-36.8%
0.00%
-100.0%
Q2 2023$51,494
+81636.5%
19,072
+463.4%
0.00%0.0%
Q1 2023$63
+293.8%
3,385
+231.2%
0.00%
+100.0%
Q4 2022$16
-100.0%
1,022
-92.7%
0.00%
-66.7%
Q3 2022$182,000
+17.4%
14,002
-4.5%
0.00%0.0%
Q2 2022$155,000
+10.7%
14,665
+25.2%
0.00%
+200.0%
Q1 2022$140,000
-7.3%
11,712
+9.9%
0.00%
-66.7%
Q4 2021$151,000
+12.7%
10,655
-18.4%
0.00%0.0%
Q3 2021$134,000
-15.7%
13,064
+119.6%
0.00%
-25.0%
Q2 2021$159,000
-55.5%
5,949
-42.2%
0.00%
-33.3%
Q1 2021$357,000
+86.9%
10,292
+100.2%
0.01%0.0%
Q4 2020$191,000
-35.0%
5,141
-28.1%
0.01%
+100.0%
Q3 2020$294,000
-32.9%
7,151
-33.9%
0.00%
-83.3%
Q2 2020$438,000
+73.1%
10,812
+83.3%
0.02%
-14.3%
Q4 2019$253,000
+12550.0%
5,899
+13306.8%
0.02%
Q2 2019$2,000
-94.4%
44
-93.4%
0.00%
-100.0%
Q1 2019$36,000
+800.0%
668
+650.6%
0.00%
Q4 2018$4,000
-90.7%
89
-87.5%
0.00%
-100.0%
Q3 2018$43,000
+377.8%
714
+290.2%
0.00%
+200.0%
Q4 2017$9,000
-96.3%
183
-96.0%
0.00%
-95.0%
Q3 2017$245,000
+2127.3%
4,560
+1188.1%
0.02%
+1900.0%
Q2 2017$11,000
-80.4%
354
-86.5%
0.00%
-83.3%
Q4 2016$56,000
+2700.0%
2,616
+2516.0%
0.01%
Q3 2016$2,000
-66.7%
100
-50.0%
0.00%
-100.0%
Q4 2015$6,000
-50.0%
200
-62.8%
0.00%0.0%
Q3 2015$12,000
+140.0%
537
+165.8%
0.00%
Q2 2015$5,000
-78.3%
202
-73.2%
0.00%
-100.0%
Q1 2015$23,0007540.00%
Other shareholders
FIBROGEN INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$7,880,0004.60%
ARMISTICE CAPITAL, LLC 4,456,000$57,973,0001.01%
Intercontinental Wealth Advisors, LLC 191,300$2,489,0000.78%
BHK Investment Advisors, LLC 87,450$1,138,0000.57%
Soleus Capital Management, L.P. 234,026$3,045,0000.41%
Tri Locum Partners LP 74,348$967,0000.26%
Point72 Asset Management, L.P. 4,777,700$62,158,0000.25%
PRIMECAP MANAGEMENT CO/CA/ 13,179,897$171,470,0000.17%
Newbridge Financial Services Group, Inc. 20,285$264,0000.16%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,430,526$18,611,0000.15%
View complete list of FIBROGEN INC shareholders